25 Aug 2020 Governance

Angela Smith-Morgan to step down from her role as Co CEO of Leukaemia UK

After eight successful years with us, Angela Smith-Morgan will be stepping down from her role as Co CEO of Leukaemia UK on 3rd September.

Angela was responsible for driving through the merger with Leuka in November 2019, and is now leaving the charity in a strong position to build on the remarkable transformation she engineered.

She has been a valued Co CEO of the merged charity and a visionary sole CEO of the original charity. We thank her for her outstanding work on our behalf and wish her the very best in the future.

Related posts

John Goldman Fellowships for 2022 open in December

16 November 2021

John Goldman Fellowships for 2022 open in December

Leukaemia UK is delighted to continue its investment and funding for early career scientists and clinicians in 2022.

Friends and family of Leicestershire woman who died from rare cancer campaign for more research and awareness

2 August 2023

Friends and family of Leicestershire woman who died from rare cancer campaign for more research and awareness

The family of a Leicestershire woman who died in July 2022, on the day of her leukaemia diagnosis, has raised over £17,000 in her memory to support Leukaemia UK. On…

Leukaemia UK appoints new CEO

27 August 2020

Leukaemia UK appoints new CEO

The trustees of Leukaemia UK are delighted to announce that they have appointed Fiona Hazell as CEO of Leukaemia UK. Fiona brings a strong track record in not-for-profit leadership, starting her role on 9th September 2020.

New research could help detect leukaemia earlier in older people

1 August 2022

New research could help detect leukaemia earlier in older people

New research findings, published in the scientific journal Nature Medicine, could help better predict risk of leukaemia in older people and ultimately improve early diagnosis of the disease. The research…